XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balances, in shares at Dec. 31, 2020   243,752,000      
Balances at Dec. 31, 2020 $ 693,479 $ 2,438 $ 3,610,297 $ (2,908,120) $ (11,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 2,060     2,060  
Other comprehensive income (loss) 24,636       24,636
Common stock issued under stock-based compensation plans, net (in shares)   (282,000)      
Common stock issued/canceled under long-term incentive plans and director fees and options, net 331 $ (3) 334    
Balances, in shares at Mar. 31, 2021   243,470,000      
Balances at Mar. 31, 2021 720,506 $ 2,435 3,610,631 (2,906,060) 13,500
Balances, in shares at Dec. 31, 2020   243,752,000      
Balances at Dec. 31, 2020 693,479 $ 2,438 3,610,297 (2,908,120) (11,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (20,562)        
Other comprehensive income (loss) 16,040        
Balances, in shares at Sep. 30, 2021   256,929,000      
Balances at Sep. 30, 2021 813,739 $ 2,569 3,734,948 (2,928,682) 4,904
Balances, in shares at Mar. 31, 2021   243,470,000      
Balances at Mar. 31, 2021 720,506 $ 2,435 3,610,631 (2,906,060) 13,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 32,146     32,146  
Other comprehensive income (loss) (6,043)       (6,043)
Common stock issued for investment (in shares)   12,786,000      
Common stock issued under "at the market" stock offering 118,777 $ 128 118,649    
Common stock issued under stock-based compensation plans, net (in shares)   792,000      
Common stock issued/canceled under long-term incentive plans and director fees and options, net 3,023 $ 7 3,016    
Balances, in shares at Jun. 30, 2021   257,048,000      
Balances at Jun. 30, 2021 868,409 $ 2,570 3,732,296 (2,873,914) 7,457
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (54,768)     (54,768)  
Other comprehensive income (loss) (2,553)       (2,553)
Common stock issued under stock-based compensation plans, net (in shares)   (119,000)      
Common stock issued/canceled under long-term incentive plans and director fees and options, net 2,651 $ (1) 2,652    
Balances, in shares at Sep. 30, 2021   256,929,000      
Balances at Sep. 30, 2021 813,739 $ 2,569 3,734,948 (2,928,682) 4,904
Balances, in shares at Dec. 31, 2021   256,919,000      
Balances at Dec. 31, 2021 800,262 $ 2,569 3,738,347 (2,939,442) (1,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 7,682     7,682  
Other comprehensive income (loss) (4,758)       (4,758)
Common stock issued for investment (in shares)   22,053,000      
Common stock issued under "at the market" stock offering 98,499 $ 220 98,279    
Common stock issued under stock-based compensation plans, net (in shares)   1,862,000      
Common stock issued/canceled under long-term incentive plans and director fees and options, net (1,711) $ 19 (1,730)    
Balances, in shares at Mar. 31, 2022   280,834,000      
Balances at Mar. 31, 2022 899,974 $ 2,808 3,834,896 (2,931,760) (5,970)
Balances, in shares at Dec. 31, 2021   256,919,000      
Balances at Dec. 31, 2021 800,262 $ 2,569 3,738,347 (2,939,442) (1,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (127,196)        
Other comprehensive income (loss) $ 46,906        
Common stock issued for investment (in shares) 22,053,275        
Balances, in shares at Sep. 30, 2022   280,836,000      
Balances at Sep. 30, 2022 $ 821,589 $ 2,808 3,839,725 (3,066,638) 45,694
Balances, in shares at Mar. 31, 2022   280,834,000      
Balances at Mar. 31, 2022 899,974 $ 2,808 3,834,896 (2,931,760) (5,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (77,434)     (77,434)  
Other comprehensive income (loss) 32,514       32,514
Common stock issued under stock-based compensation plans, net (in shares)   (29,000)      
Common stock issued/canceled under long-term incentive plans and director fees and options, net 2,127 $ 0 2,127    
Balances, in shares at Jun. 30, 2022   280,805,000      
Balances at Jun. 30, 2022 857,181 $ 2,808 3,837,023 (3,009,194) 26,544
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (57,444)     (57,444)  
Other comprehensive income (loss) 19,150       19,150
Common stock issued under stock-based compensation plans, net (in shares)   31,000      
Common stock issued/canceled under long-term incentive plans and director fees and options, net 2,702 $ 0 2,702    
Balances, in shares at Sep. 30, 2022   280,836,000      
Balances at Sep. 30, 2022 $ 821,589 $ 2,808 $ 3,839,725 $ (3,066,638) $ 45,694